Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Bernard Gilly, PhD

Advertisement

CEO, Gensight Biologics

Articles by Bernard Gilly, PhD

Pipeline: New therapies to come for debilitating eye diseases

ByGretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Bernard Gilly, PhD
November 12th 2020

New drug from Gensight Biologics hits pipeline

Advertisement

Latest Updated Articles

  • Pipeline: New therapies to come for debilitating eye diseases
    Pipeline: New therapies to come for debilitating eye diseases

    Published: November 12th 2020 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

Early SPECTRUM results outline week 8 real-world outcomes with aflibercept 8 mg

2

The Vision Council report shows optical industry value growth amid lower volumes in 2025

3

Contact Lens Institute rings in 2026 Visionaries

4

Higher head elevation during sleep may be associated with higher IOP, study suggests

5

Myra Vision treats first patient in ADAPT trial for Calibreye TGT Surgical System

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us